Most cancers sufferers don’t simply struggle the illness – they struggle the system. At present, life-saving remedies are routinely delayed by days and even weeks on account of guide, error-prone workflows. To unravel this, RISA Labs has raised a $3.5M funding spherical to assist healthcare organizations eradicate one of the crucial persistent boundaries to well timed most cancers care: prior authorization delays. RISA Labs has already confirmed that sooner care is feasible by dramatically lowering guide workflows and administrative burden.
The seed was led by Binny Bansal (Flipkart co-founder) with participation from Oncology Ventures, Basic Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta. The capital will speed up deployments within the subsequent 100 most cancers facilities throughout the nation throughout the subsequent two years.
Additionally Learn: How AI may help Companies Run Service Centres and Contact Centres at Decrease Prices?
RISA founders: Kumar Shivang and Kshitij Jaggi.
“Prior authorizations stay one of many least automated elements of our healthcare system,” stated Ben Freeberg, Managing Companion at Oncology Ventures. “In oncology, the stakes are greater. 70% of most cancers sufferers expertise delays in care due to prior authorization necessities. In 33% of these circumstances, the delay is one month—a time window that may improve the chance of loss of life by 13% in sure most cancers varieties. The present system isn’t simply inefficient – it’s harmful.”
RISA’s platform—Enterprise Working System as a Service (BOSS) – shouldn’t be one other automation bot or AI assistant. It’s a full-stack orchestration engine constructed for the vertical complexity of healthcare, As a substitute of counting on people to push paperwork or brittle bots that break when methods change, BOSS decomposes complicated workflows into micro-tasks, then delegates them to a community of clever brokers—LLMs, digital twins, and reinforcement learners, extending throughout an establishment’s complete software program stack. This permits BOSS to create a parallel digital workforce, working on behalf of groups and alongside them. A 1,000-person establishment can perform like a 2,000-person one in a single day, with digital brokers making up half the workforce.
“We’ve had Home windows, we’ve had Linux, we’ve had Mac, every OS helped people extract extra from machines. However now, we’re drowning in software program. There’s an excessive amount of of it, and a scarcity of expert labor to function it. Software program that was imagined to get work achieved has change into work itself,” Kshitij Jaggi, co-founder and CEO of RISA Labs provides. “BOSS is an AI OS designed for the post-ChatGPT period : the place work is now not about studying instruments, however merely expressing intent.”
At a number one US most cancers heart, BOSS decreased prior authorization occasions from half-hour to beneath 5. In only a few months, it processed over $1 million in drugs, freed up 80 p.c of workers time, and lower administrative prices by 66 p.c.
“Most cancers care is time delicate. Each delay in remedy can have an effect on outcomes. Prior authorizations proceed to sluggish us down. What RISA is constructing isn’t just good expertise. It removes boundaries so our groups can transfer sooner and keep centered on what issues most: caring for sufferers,” stated Dr. Jeffrey Vacirca, CEO of New York Most cancers and Blood Specialists.
Based mostly in Silicon Valley, RISA is based by IIT Kanpur alumni and repeat founders, Kshitij Jaggi (CEO) and Kumar Shivang (CTO) who’ve been mates for greater than a decade now, who’ve beforehand constructed and scaled City Well being. Their frustration with fragmented, sluggish, and error-prone healthcare workflows throughout that journey impressed the duo to take a systems-first method, main them to develop a foundational AI working system that may simulate, perceive, and orchestrate complete institutional workflows from finish to finish.
“BOSS is low-entropy system design to convey move state in system-2 pondering for LLMs; it goals to maximise AI brokers’ usefulness for essential issues like oncology operations,” stated Kumar Shivang, co-founder & CTO of RISA. “Its orchestration layer then turns that intelligence into exact, real-time execution with integrations with methods of report like Flatiron Well being’s EMR.”
Newest Information: LambdaTest Launches HyperExecute MCP Server to Automate Testing Setups with AI
RISA’s founding workforce first explored these ideas by way of analysis, co-authoring ‘Digital Twin Ecosystem in Oncology Medical Operations’—an early effort to check smarter, AI-driven most cancers care workflows. This foundational work laid the conceptual groundwork that later translated into tangible enhancements in real-world oncology operations.
RISA’s platform indicators a broader shift in enterprise AI. “As AI brokers unbundle the $4.6 trillion providers trade, RISA’s BOSS leads the way in which—confirmed in oncology and constructed to scale,” stated Binny Bansal, co-founder of Flipkart and lead investor.”
Wanting forward, RISA plans to increase throughout a number of nodes throughout the oncology ecosystem, positioning itself because the AI transformation accomplice for each operational and medical workflows. This consists of enabling coordination and intelligence throughout suppliers, life sciences organizations, and different stakeholders all through the journey of a drug – extending the corporate’s long run imaginative and prescient to constructing a unified layer for AI-driven orchestration in oncology.
[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
